Indivior PLC (INDV) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
Indivior (INDV) Q1 2026: Sublocade Revenue Jumps 32% as EBITDA Margin Hits 51%
April 30, 2026
-
Indivior (INDV) Q4 2025: Sublocade Dispense Units Up 12% as EBITDA Margin Expands 500bps
February 26, 2026
-
Indivior (INDV) Q3 2025: $150M Cost Cuts Reshape Operating Model Ahead of Phase Two
October 30, 2025
-
Indivior (INDV) Q2 2025: $100M Cost Savings Offset Suboxone Price Erosion, Sublocade Share Holds
July 06, 2025